EKF Diagnostics Holdings

ADL Health is a Texas based PCR-focused testing laboratory certified under the Clinical Laboratory Improvement Amendments.

Trellus Health Inc. is a digital health company that specializes in providing resilience-driven solutions for chronic gastrointestinal conditions, particularly inflammatory bowel disease and irritable bowel syndrome. Founded in 2020 and headquartered in White Plains, New York, with an additional office in Cardiff, United Kingdom, Trellus Health offers a telehealth-based, multidisciplinary clinic that coordinates access to high-quality clinical care. Its connected care platform delivers whole-person care, integrating clinical and behavioral health services to enhance patient outcomes and reduce healthcare costs. The company's evidence-based management program incorporates a resilience-based behavior change approach, live one-on-one coaching, and user-friendly applications designed to improve overall resilience, promote better self-management, and support mental health for individuals facing these chronic conditions.

DiaSpect Medical AB develops hemoglobin measurement systems.

Selah Genomics Inc. is a clinical diagnostic specialist based in Greenville, South Carolina, that delivers advanced molecular and genomic diagnostic services to healthcare providers and the pharmaceutical industry in the United States. Established in 2006 and formerly known as Lab21 Inc., the company focuses on enhancing diagnostic testing services, particularly in women's health and the management of chronic conditions. Selah Genomics specializes in personalized treatment plans for various cancer types, utilizing detailed genomic profiling derived from patient tumors. Its comprehensive service offerings include next-generation sequencing, companion diagnostics, RNA sequencing, targeted sequencing, biorepository services, quantitative PCR, bioinformatics, and nucleic acid extraction. By supporting early-stage drug development, clinical trials, and regulatory processes, Selah Genomics aims to improve patient outcomes through more personalized treatment and effective patient monitoring.

Separation Technology Inc. provides centrifugation solutions to the laboratory marketplace.

360 Genomics Ltd. develops molecular diagnostic technologies for the detection of mutations in key oncogenes.

tanbio Laboratory, L.P. manufactures medical devices and products for in-vitro diagnostic companies in the clinical laboratory market.

Argutus Medical is a leading company specializing in the development and manufacturing of organ injury assays, particularly focused on acute kidney and liver injuries. The company creates ELISA tests and lateral flow rapid test devices for detecting nephrotoxicity and hepatotoxicity. Additionally, Argutus Medical produces a range of other assays, including OxyDNA, which tests for oxidative DNA damage. Originally part of Biotrin International, Argutus Medical became an independent entity in 2008 and was subsequently acquired by EKF Diagnostics Holdings plc in 2010. This acquisition has enabled Argutus Medical to concentrate on biomarker discovery and the development of innovative biomarker assays, with its operational base located in Dublin, Ireland.

Quotient Diagnostics Ltd. develops a testing technology for the diagnosis, treatment, and management of diabetes and associated diseases.